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Frontiers in radionuclide imaging and therapy, a chemical 
journey from naturally radioactive elements to targeted 
theranostic agents 
 
It gives us great honour to welcome you to the 2017 Dalton Transactions themed issue: 
Frontiers in Radionuclide Imaging and Therapy, A chemical journey from naturally radioactive 
elements to targeted theranostic agents. This special issue recognises the contributions of 
Professor Isabel Santos from the Instituto Superior Técnico at the University of Lisbon, to the 
advancement of science in the field of radiopharmaceutical chemistry on the occasion of her 
recent retirement. Professor Santos has been working over the years on the coordination 
chemistry of f-elements, namely actinides (U(III/IV)) and lanthanides (e.g. Sm, Ho), as well as 
of d-transition metal compounds, mainly Re and 99mTc. Some of those metal complexes 
featured interesting properties for applications in molecular imaging, targeted radionuclide 
therapy and theranostics. She has published more than 200 publications, and has been 
responsible for numerous research projects. Professor Santos has been the head of the 
Radiopharmaceutical Sciences Group for several years, and between 2013 - 2015 she was the 
first President of the ͞Centre for NuĐlear “ĐienĐes and TeĐhnologǇ͟ (C2TN) in Lisbon, a 
national research facility rated as ͞EǆĐellent͟ ďǇ the Portuguese Science Foundation. We 
would like to emphasise that Professor Santos not only made outstanding contributions to 
the inorganic chemistry community, but also pioneered in Portugal and Europe a move 
towards inclusion of women in science, where gender equality is currently a relevant concern 
in the academic environment worldwide. Indeed, she has been a role model for many of her 
female students and co-workers, not to mention her national and international collaborators. 
The recognized inter-/multi-disciplinary nature of the research domains proposed in this 
themed issue reflects Professor Santos´ varied scientific interests, which span basic research 
in inorganic/organometallic chemistry to more application oriented studies. Indeed, this issue 
provides a broad spectrum of studies and views on radiometal-based molecular complexes 
and nanoplatforms for molecular imaging, systemic radiotherapy and theranostics, with 
approximately 30 papers, authored by well-known experts in their field. There are articles 
focused on the production and radiochemistry of radiometals, such as those by Abrunhosa 
and co-workers (Fast and cost-effective cyclotron production of 61Cu using a natZn liquid 
target: an opportunity for radiopharmaceutical production and R&D) and Jurisson and co-
workers (Chemistry and Radiochemistry of Arsenic, Rhenium and Rhodium Isotopes Relevant 
to Radiopharmaceutical Applications: Development of High Specific Activity Radionuclides for 
Imaging and Treatment). Within this framework, the study presented by Oehlke and co-
workers (Measurement of reaction kinetics of [177Lu]Lu-DOTA-TATE using a microfluidic 
system) is also particularly innovative as it demonstrates that microfluidic synthesis 
techniques can become a viable alternative to the conventional, batch-wise radiolabelling 
techniques. Also, in the context of new radiolabelling procedures, Reid and co-workers report 
on a new radiofluorination method through Cl/18F halide exchange ([AlCl3(BnMe2-tacn)] – a 
new metal chelate scaffold for radiofluorination by Cl/18F exchange). 
The introduction of innovative bifunctional chelators for stabilization of radiometals such 
technetium, gallium, copper or other relevant radioisotopes for molecular nuclear imaging or 
targeted radiotherapy applications has been explored by the research groups of Abram 
(Thiourea Derivatives as Chelating Agents for Bioconjugation of Rhenium and Technetium), 
Maina-Nock (DOTA-to-DATA Chelator-Switch for 68Ga-Labeling of [Tyr3]Octreotide: 
Preclinical Comparison of the Radioligands), Dénat (MANOTA: a promising bifunctional 
chelating agent for copper-64 immunoPET), Blower (copper complexes with dissymmetrically 
substituted bis(thiosemicarbazone) ligands as a basis for PET radiopharmaceuticals: control 
of redox potential and lipophilicity) and Orvig (H4octapa: Synthesis, Solution Equilibria and 
Complexes with Radiopharmaceutically Useful Metal Ions). 
Novel rhenium and technetium organometallic complexes potentially useful as targeted 
imaging probes by employing bioorthogonal chemistry or complexes useful as theranostic 
molecular tools using the matched pair 99mTc/Re have been introduced by Valliant´s 
(Preparation of tetrazine-containing [2 + 1] complexes of 99mTc and in vivo targeting using 
bioorthogonal inverse) and Alberto´s (Structure and Reactivities of Rhenium and Technetium 
bis- -arene)2]+) groups, respectively. 
Noteworthy, reports on radiometal complexes aimed at targeting organs such as the heart 
(Liu and co-workers, 99mTc(III) Complexes as Radiotracers for Myocardial Perfusion Imaging 
and 99mTc-3Cboroxime: A Novel 99mTc(III) Complex [99mTcCl(CDO)(CDOH)2B-3C] (CDOH2 = 
Cyclohexanedione Dioxime; 3C-B(OH)2 = 3-(Carbamoylphenyl)boronic Acid) with High Heart 
Uptake and Long Myocardial Retention), cell-membrane transporters (Correia and co-
workers, Technetium-99m complexes of L-arginine derivatives for targeting amino acid 
transporters) and thrombus (Caravan and co-workers, Fibrin-Targeting Probes for Thrombus 
Imaging) are also included in this issue. Moreover, imaging of inflammation and infection in 
vivo is also a subject of relevant interest as addressed by Kniess and co-workers 
(99mTechnetium-based Small Molecule Radiopharmaceuticals and Radiotracers Targeting 
Inflammation and Infection) and by Drlica and co-workers (Fluoroquinolones as imaging 
agents for bacterial infection) in the corresponding Perspectives. Two Perspectives papers 
describe innovative methodologies towards the development of novel peptide-based 
molecular probes for targeting E-selectin (Iranzo and co-workers, A computational and 
experimental study to develop E-selectin targeted peptides for molecular imaging probes) and 
provide an overview on the use for metal complexes for multimodal imaging, which is 
currently considered a hot topic (Tóth and co-workers, Metal complexes for multimodal 
imaging of misfolded protein-related diseases).  
Apart from the molecular-based approaches, this special issue also comprises two full articles 
in which radiolabelled gold-based nanoparticles (AuNp) have been studied. For example, in 
the paper by Paulo and co-workers it has been demonstrated that thiolated bombesin-
containing AuNp are potentially useful as target-specific GSH-mediated drug delivery systems 
(IŶ Vitro/IŶ Vivo ͞PeeliŶg͟ of MultilaǇered AŵiŶoĐarďoǆǇlate Gold NaŶopartiĐles EvideŶĐed ďǇ 
a Kinetically Stable 99mTc-label: Implications for Glutathione-mediated Drug Release). The 
work presented by Khoobchandani and co-workers (Mangiferin Functionalized Radioactive 
Gold Nanoparticles (MGF- 198AuNPs) in Prostate Tumor Therapy: Green Nanotechnology of 
Production, In Vivo Tumor Retention and Evaluation of Therapeutic Efficacy) shows that a 
198Au-labeled Np (beta emitter) promotes tumour reduction in a preclinical model of 
prostate cancer. 
Concerning the development of novel theranostics, another hot topic, the articles by Bodio 
and co-workers (In vitro and in vivo trackable titanocene-based complexes using optical 
imaging or SPECT) and Gomez Quiroga and co-workers (Combining Imaging and Anticancer 
Properties with New Heterobimetallic Pt(II)/M(I) (M = Re, 99mTc) Complexes) are exquisite 
examples of such type of approach, where (bi)metallic complexes containing simultaneously 
a cytotoxic unit and a nuclear or optical imaging probe were synthesized and evaluated 
biologically with relevant results for further application. 
We would like also to highlight the contributions with an higher clinical component, that is 
the case of the Perspective by Costa and co-workers (Radionuclides in oncology clinical 
practice – review of the literature), which discusses clinical applications of therapeutic 
radionuclides commonly used in the clinical practice of oncology; or the full article by Müller 
and co-workers (Clinical evaluation of the radiolanthanide terbium-152: First-in-human 
PET/CT with 152Tb-DOTATOC), describing the first-in-human PET/CT with 152Tb-DOTATOC; 
and the full article by Brechbiel and co-workers (Comparative Studies on the Therapeutic 
BeŶefit of Targeted α-Particle Radiation Therapy for the Treatment of Disseminated 
Intraperitoneal Disease), which reviews the use of the α-emitting particles radionuclides for 
radioimmunotherapy. These contributions were organized and written to reach the broader 
audience of the inorganic chemistry/organometallic community interested in biomedical 
applications of radiometals. 
 
Finally, we would like to thank the editorial staff at Dalton Transactions for making this 
themed issue possible. All the authors as well as reviewers are also acknowledged for their 
efforts and relevant contributions, and we hope this special issue will encourage further 
developments in this exciting research field. 
 
Please enjoy and get inspired! 
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